Vimseltinib (DCC-3014) MOTION
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
March 16, 2022
End Date
January 26, 2023
Administered By
Duke Cancer Institute
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
March 16, 2022
End Date
January 26, 2023